Syndax Pharmaceuticals, Inc.SNDXNASDAQ

Loading chart...

Want to monitor SNDX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr. , building d, floor 3, waltham, ma 02451.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Briggs Morrison

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

Columbia Sportswear's Plunge Doesn't Make The Stock A Good Fit

A Generational Lithium Franchise in the Making: Elektros Inc. Elevates Institutional-Grade Investor Communications to Advance Critical Minerals Growth

ARDT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

3 Reasons to Buy Uber Stock Like There's No Tomorrow

Apple Loses More AI Researchers to Meta and Google

A March Decision That Could Change Protalix BioTherapeutics Outlook

Is This Short-Term Bond ETF a Buy After Merit Financial Bought Shares Worth $8.6 Million?

Is UPS Stock a Buy Now?

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BellRing Brands, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BRBR

Oracle amps up its AI bet with a plan to raise as much as $50 billion this year

AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics

AAR Corp.: Well Positioned To Capitalize On Current Demand/Supply Dynamic

Why AT&T Stock Surged This Week

Disney may soon have a new CEO. Here's who it might be.

This Dirt Cheap Stock Is Expected to Quadruple Its Earnings This Year

OWL INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue Owl Capital

Forget Tech Stocks: The Utility That's Solving AI's Biggest Problem